DTL
ATYR

Dynamic Technology Lab’s aTyr Pharma ATYR Stock Holding History

Dynamic Technology Lab’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-1,382
Closed -$68K – 1373
2017
Q1 		$68K Buy
+1,382
New +$63.2K 0.02% 910
2016
Q3 		– Sell
-1,061
Closed -$41K – 1198
2016
Q2 		$41K Buy
+1,061
New +$49.3K 0.01% 820

Other funds holding ATYR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GHCM
Glen Harbor Capital Management San Diego, California $4.82B AUM 4.69% 1-Year Est. Return
MCIM
Meadow Creek Investment Management Atlanta, Georgia $5.09B AUM 5.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dynamic Technology Lab's ATYR Position: Q2 2017 in Review

Dynamic Technology Lab sold out of aTyr Pharma (ATYR) in Q2 2017, closing a stake of 1,382 shares — an estimated $68K sold.

Dynamic Technology Lab first reported a position in ATYR in Q2 2016 and held it in 2 quarters. The position peaked at $68K in Q1 2017. 32 funds tracked by Wall St. Rank hold ATYR as of Q2 2017.

  • Dynamic Technology Lab reported no remaining aTyr Pharma position as of Q2 2017 after selling out during the quarter.
  • Dynamic Technology Lab sold 1,382 aTyr Pharma shares in Q2 2017, an estimated $68K.
  • Dynamic Technology Lab first reported a position in aTyr Pharma in Q2 2016 and held it in 2 quarters.
  • Dynamic Technology Lab's aTyr Pharma position peaked at $68K in Q1 2017.
  • 32 funds tracked by Wall St. Rank held aTyr Pharma as of Q2 2017.

Based on Dynamic Technology Lab's 13F filing for Q2 2017, filed 17 Aug 2017.